Ionis Pharmaceuticals, Inc. (IONS) stock analysis

IONS · Ionis Pharmaceuticals, Inc.

Latest recorded price: USD 28.01

Sector and industry: Healthcare · Biotechnology

Fiscal 2025 figures: revenue growth 17.1%, free cash flow margin -33.9%, ROIC -72.2%. The model flags 2 risk signals for this company (1 high severity).

Similar companies in Healthcare